Vyfemla

Endometriosis, Low Testosterone, Osteoporosis + 16 more

Treatment

20 Active Studies for Vyfemla

Treatment for

Endometriosis

What is Vyfemla

NorethisteroneThe Generic name of this drug

Treatment SummaryNorethisterone, also known as norethindrone, is a synthetic hormone used to treat menstrual irregularities, endometriosis, and other conditions. It is a second-generation progestin, meaning it is a more potent form of progesterone. Norethisterone was first developed in 1951, and was initially used to treat menstrual problems. In 1962, it was approved for use as an oral contraceptive.

Neconis the brand name

Vyfemla Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Necon

Norethisterone

1967

347

Effectiveness

How Vyfemla Affects PatientsNorethisterone is a synthetic hormone pill used as a form of birth control or to treat other hormone-related conditions such as menopause and endometriosis. It is much stronger than the hormone progesterone that is naturally produced in the body. Norethisterone works to change the function of the cervix and uterus, as well as how the pituitary gland makes hormones that control ovulation. There is evidence that taking this pill may slightly increase the risk of developing breast cancer, so it is important to be aware of this risk and to do regular self-examinations for any changes or masses

How Vyfemla works in the bodyNorethisterone works by binding to progesterone receptors in different parts of the body, like the reproductive tract, breast, pituitary, hypothalamus, skeletal tissue and central nervous system. It thickens cervical mucus to prevent sperm from entering the uterus, and makes the endometrium inhospitable for implantation. It also works to suppress the release of hormones that cause follicles to grow and ovulation to occur. When used for hormone replacement therapy in menopausal women, it helps prevent endometrial hyperplasia, which can increase the risk of endometrial cancer. Norethisterone has a

When to interrupt dosage

The dosage of Vyfemla is contingent upon the identified ailment, including Atrophic, Fracture and Hormone Replacement Therapy. The measure of dosage changes as per the delivery approach (e.g. Oral or Tablet) mentioned in the table below.

Condition

Dosage

Administration

Atrophic

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hot flashes

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormone Replacement Therapy

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

female castration

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Low Testosterone

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

hypoestrogenism

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Therapeutic procedure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Fracture

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Ovarian Failure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Postmenopausal Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Vasomotor System

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Oral Contraceptives

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormonal Contraception

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Estrogen Deprivation Symptoms

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Menopause

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Birth Control

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Warnings

Vyfemla Contraindications

Condition

Risk Level

Notes

active liver disease

Do Not Combine

Thrombophilia

Do Not Combine

Vaginal Hemorrhage

Do Not Combine

Malignant Neoplasms

Do Not Combine

Benign hepatic neoplasm

Do Not Combine

Breast Cancer

Do Not Combine

Thromboembolism

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Norethisterone may interact with Pulse Frequency

There are 20 known major drug interactions with Vyfemla.

Common Vyfemla Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Norethisterone.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Norethisterone.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Norethisterone.

Clomipramine

Major

The metabolism of Clomipramine can be increased when combined with Norethisterone.

Copanlisib

Major

The metabolism of Copanlisib can be decreased when combined with Norethisterone.

Vyfemla Toxicity & Overdose RiskThe lowest toxic dose of oral contraceptives in mice is 6g/kg, and in women is 42mg/kg. No serious health issues have been reported from taking too many oral contraceptives, even among children. Overdosing on oral contraceptives may cause severe nausea and vomiting.

image of a doctor in a lab doing drug, clinical research

Vyfemla Novel Uses: Which Conditions Have a Clinical Trial Featuring Vyfemla?

160 active studies are presently assessing the potential of Vyfemla to ameliorate Birth Control, Atrophic changes and Low Testosterone levels.

Condition

Clinical Trials

Trial Phases

Endometriosis

32 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1, Phase 2, Phase 4, Phase 1

Osteoporosis

40 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4, Phase 3

Estrogen Deprivation Symptoms

0 Actively Recruiting

Oral Contraceptives

2 Actively Recruiting

Not Applicable

Therapeutic procedure

0 Actively Recruiting

Menopause

0 Actively Recruiting

Hormone Replacement Therapy

0 Actively Recruiting

Atrophic

6 Actively Recruiting

Phase 2, Phase 4, Not Applicable

Low Testosterone

15 Actively Recruiting

Phase 1, Phase 4, Phase 2, Not Applicable

Hot flashes

22 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 4, Early Phase 1

Postmenopausal Osteoporosis

3 Actively Recruiting

Not Applicable, Phase 4

Birth Control

31 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Early Phase 1

Fracture

0 Actively Recruiting

female castration

0 Actively Recruiting

hypoestrogenism

2 Actively Recruiting

Phase 4

Vasomotor System

0 Actively Recruiting

Endometriosis

1 Actively Recruiting

Phase 4

Ovarian Failure

2 Actively Recruiting

Not Applicable, Phase 1

Hormonal Contraception

0 Actively Recruiting

Vyfemla Reviews: What are patients saying about Vyfemla?

5Patient Review

8/9/2017

Vyfemla for Abnormally Long or Heavy Periods

I've been on this medication for a year and it has helped to regulate my cycles. They were irregular before, but now they are much lighter. I don't even bleed; I only spot occasionally.

4.7Patient Review

3/18/2019

Vyfemla for Abnormally Long or Heavy Periods

I switched to this brand of birth control about six months ago to help with my acne and cramping. My acne is much better, though the cramps are still an issue. I have gained some weight, but in my opinion, it's worth it!

4Patient Review

8/2/2016

Vyfemla for Birth Control

4Patient Review

8/2/2016

Vyfemla for Abnormally Long or Heavy Periods

This medication was very effective in stopping my abnormal bleeding. However, the side effects were brutal. I experienced severe chest pain and difficulty breathing to the point of not being able to get out of bed for days at a time.

3.7Patient Review

1/9/2020

Vyfemla for Acne

I experienced some major cramping and breakthrough bleeding while on this medication. It would happen if I had sex, and it was like period bleeding. However, it did clear up my skin.

3.3Patient Review

8/9/2020

Vyfemla for Birth Control

I've only been on this pill for a week, and I've already experienced some serious side effects like mood swings, vomiting, and spotting. I'm going to give it a month to see if my body gets used to it, but so far I'm not impressed.

Patient Q&A Section about vyfemla

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Vyfemla generic for?

"Vyfemla is a drug taken orally that is indicated for preventing pregnancy. It is available in generic form."

Answered by AI

Is Azurette progestin only?

"This medication contains two hormones: a progestin (desogestrel) and an estrogen (ethinyl estradiol)."

Answered by AI

Does Vyfemla cause weight gain?

"The most commonly reported side effects were headaches, vaginal candidiasis, nausea, menstrual cramps, breast tenderness, abdominal pain, mood changes, bacterial vaginitis, acne, irregular uterine bleeding, and weight gain."

Answered by AI

What is Yaz called now?

"There are two birth control pills on the market today, Yaz and Loryna. Loryna is a generic version of Yaz."

Answered by AI

Clinical Trials for Vyfemla

Image of University of Colorado Department of Obstetrics & Gynecology in Aurora, United States.

Elagolix for Infertility

This trial is testing a new medication given by mouth to women with endometriosis who are trying to get pregnant through IVF. The main goal is to see if the medication can increase the chances

University of Colorado Department of Obstetrics & Gynecology (+4 Sites)Hugh Taylor, MD

Image of University of Michigan in Ann Arbor, United States.

My Pelvic Plan Website for Endometriosis

This trial aims to see if an online self-management program can help patients with Chronic Pelvic Pain feel better. The researchers believe that patients using the program will have less pain, better physical function, and

Waitlist Available

University of MichiganSara Till, MD

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Desogestrel / Ethinyl Estradiol Pill for Birth Control

This trial aims to understand how differences in our DNA can affect how our bodies process hormones in birth control pills, potentially influencing their effectiveness in preventing pregnancy and causing different side effects in individuals. Participants will take

Waitlist Available

University of Colorado Anschutz Medical Campus (+1 Sites)Aaron M Lazorwitz, MD, PhD

Image of McLean Function Measurement Lab in Ottawa, Canada.

Repetitive Transcranial Magnetic Stimulation for Endometriosis

This trial aims to improve pain outcomes for Canadian women with endometriosis. It will test the effectiveness of a repetitive transcranial magnetic stimulation (rTMS) intervention for reducing pain in individuals

No Prior Treatment

McLean Function Measurement LabLinda McLean, PhD

Have you considered Vyfemla clinical trials? We made a collection of clinical trials featuring Vyfemla, we think they might fit your search criteria.

Explore trials for Vyfemla

Image of University of Central Florida in Orlando, United States.

Wrist/hand immobilization for Menstruation

"This trial aims to understand why females tend to get more hand and wrist injuries compared to males in sports. The study will look at the impact of hormones, such as those from birth control, on muscle

University of Central Florida

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Transdermal Estradiol Patch +2 More for Menopause

"This trial aims to study how the decrease in estrogen during menopause affects artery health and body fat distribution in women. The researchers will investigate whether low estrogen levels lead to decreased artery function and increased fat in

Waitlist Available

University of Colorado Anschutz Medical CampusKerrie Moreau, PhD

Image of University of Kentucky in Lexington, United States.

Alendronate for Osteoporosis

This trial aims to address the issue of age-related bone loss, which is often overlooked in current osteoporosis treatments. The study compares the effectiveness of two drugs, Alendronate and Terip

Waitlist Available

University of KentuckyHartmut H Malluche, MD

Image of Hybl Sports Medicine and Performance Center in Colorado Springs, United States.

Hot Water Therapy for Menopause

Colorado Springs, CO

This trial is studying the effects of hot water therapy on menopausal women. The researchers want to see if taking hot baths for multiple days in a row can reduce hot flash symptoms and improve mood.

Hybl Sports Medicine and Performance CenterNathan Morris, PhD

Have you considered Vyfemla clinical trials? We made a collection of clinical trials featuring Vyfemla, we think they might fit your search criteria.

Explore trials for Vyfemla

Image of University of Arizona in Tucson, United States.

PhytoSERM for Hot Flashes

This trial is testing the effects of a supplement called PhytoSERM on menopausal symptoms in women. Participants will either take PhytoSERM pills or a placebo for 12 weeks. After

University of ArizonaFei Yin, PhDNeuTherapeutics

Image of Citruslabs in Santa Monica, United States.

Probiotic Supplement for Menopause Symptoms

Santa Monica, CA

This trial tests if a probiotic supplement can reduce menopause symptoms like hot flashes, night sweats, mood swings, etc. Participants take a test product or placebo daily and provide data on weight, waist, sleep, and symptoms.

Waitlist Available

Dietary Supplement

CitruslabsManeuver Marketing

Image of Planned Parenthood of Northern California in Berkeley, United States.

Ovaprene for Birth Control

This trial will study a new, non-hormonal contraceptive ring for safety, effectiveness, and acceptability.

Planned Parenthood of Northern California (+20 Sites)Christine Mauck, MDDaré Bioscience, Inc.

Image of St. Barnabas Woodlands in Pittsburgh, United States.

Denosumab +1 More for Osteoporosis

This trial aims to show that a new medication called Denosumab can help older adults who are weak and frail by improving their muscle health, strength, mobility, and overall function.

St. Barnabas Woodlands

Have you considered Vyfemla clinical trials? We made a collection of clinical trials featuring Vyfemla, we think they might fit your search criteria.

Explore trials for Vyfemla

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security